Curling factor en es it fr

Curling factor Brand names, Curling factor Analogs

Curling factor Brand Names Mixture

  • No information avaliable

Curling factor Chemical_Formula


Curling factor RX_link

Curling factor fda sheet

Curling factor msds (material safety sheet)

Curling_factor MSDS

Curling factor Synthesis Reference

No information avaliable

Curling factor Molecular Weight

352.766 g/mol

Curling factor Melting Point

220 oC

Curling factor H2O Solubility

8.64 mg/L

Curling factor State


Curling factor LogP


Curling factor Dosage Forms

Powder; Tablet

Curling factor Indication

For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi.

Curling factor Pharmacology

Griseofulvin is a mycotoxic metabolic product of Penicillium spp. It was the first available oral agent for the treatment of dermatophytoses and has now been used for more than forty years. Griseofulvin is fungistatic with in vitro activity against various species of Microsporum Epidermophyton, and Trichophyton. It has no effect on bacteria or on other genera of fungi. Following oral administration, griseofulvin is deposited in the keratin precursor cells and has a greater affinity for diseased tissue. The drug is tightly bound to the new keratin which becomes highly resistant to fungal invasions.

Curling factor Absorption

Poorly absorbed from GI ranging from 25 to 70% of an oral dose. Absorption is significantly enhanced by administration with or after a fatty meal.

Curling factor side effects and Toxicity

Side effects are minor: headaches, gastrointestinal reactions and cutaneous eruptions

Curling factor Patient Information

Curling factor Organisms Affected

Yeast and other Trichophyton or Microsporum fungi